Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis - No Study Results Posted

Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis (ISAR-TEST-5)

This study is currently recruiting participants.

Study NCT00598533 Information provided by Deutsches Herzzentrum Muenchen

First Received: January 10, 2008 Last Updated: January 27, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2009
Estimated Primary Completion Date:	November 2009 (Final data collection date for primary outcome measure)